Global Blood Clotting Factor Market Rising Substantially

[follow_author]
  • Rising laboratory automation can fuel the growth of the market.
  • Excessive cost of fully automated coagulation analyzer will hinder the growth of the market.
  • Strict government rules & regulations regarding with the safety and efficiency of blood clot retrieval devices is restraining the market growth.

Global blood clotting factor market is estimated to rise with the substantial CAGR in the forecast period of 2019 to 2026. The imminent market report contains data for historic year 2017 and the base year calculation is 2018 and the forecast period is 2019 to 2026.The growth of the market can be attributed to prevalence of acute stroke and short window for treatment of stroke.

Market Definition: Global Blood Clotting Factor Market

Blood coagulation or coagulation is the method through which blood shifts from liquid to gel, creating clots. These clots lead to bleeding cessation. However, in individuals with liver disease, thrombophilia, and hemophilia, the coagulation process is hindered. Different testing processes for blood coagulation are used to diagnose these illnesses, which provide the hemostatic functioning status of the patients.

  • 600,000 non-fatal cases of deadly blood clots occur each year, of which 40% are blood clots in the lungs and 60% are blood clots in the legs.
  • 900,000 cases per year are now suggested by recent scientific modeling and public health statistics.
Freelance Global GigsSubmit Your Ad Here...[feedzy-rss feeds="https://freelanceglobalgigs.com/service_post/feed/" max="5" feed_title="no" refresh="1_hours" sort="date_desc" error_empty="Coming Soon." target="_blank" follow="no" summary="no" thumb="no" meta="no"]

Market Drivers

  • Rising incidence of cardiovascular diseases and blood disorders is driving the market growth.
  • Increasing condition of high-sensitivity POC coagulation testing will propel the growth of the market.
  • Advancement in technology is boosting the market growth in the forecast period.
  • Rising laboratory automation can fuel the growth of the market.

Market Restraints

  • Excessive cost of fully automated coagulation analyzer will hinder the growth of the market.
  • Less availability of skilled professional is also hampering the market in the forecast period.
  • Strict government rules & regulations regarding with the safety and efficiency of blood clot retrieval devices is restraining the market growth.

Get Sample Analysis of Global Market Information

Key Developments in the Market:

  • In October 2018, Genentech a member of Roche group received FDA approval for the drug Hemlibra. This product will help in prevention of bleeding episodes in adults and children. With this approval the company had increase its brand value in the market
  • In February, 2018, Novo Nordisk received approval for its product NoSeven RT. The product is able to act as anti-coagulating agent which will assist the company to enhance its product portfolio in the market

Competitive Analysis:

Global blood clotting factor market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of blood clotting factor market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Some of the major companies functioning in global blood clotting factor market are Novartis AG, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., BioreclamationIVT. ELEVATING SCIENCE, Life Technologies, Illumina, Inc., Agilent Technologies,Inc, GENERAL ELECTRIC, Perkinelmer, Inc., QIAGEN, Oxford Gene Technology, Pacific Biosciences of California, Inc., BGI, Eurofins Scientific, Quest Diagnostics Incorporated,  Novogene Corporation, Promega Corporation, Luminex Corporation, TAKARA BIO INC, Danaher, ELITechGroup, MYRIAD GENETICS, INC, AutoGenomics, Biocartis, IntegraGen and Interpace Diagnostics group, inc, among others.

[bsa_pro_ad_space id=4]

Rashi Pande

About Us Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. 
https://www.databridgemarketresearch.com/ [follow_author]

Leave a Reply